Quantum-Si Incorporates Inducement Equity Plan to Attract Talent and Drive Innovation

Quantum-Si Strengthens Workforce with New Inducement Equity Plan

Quantum-Si Incorporated, recognized as The Protein Sequencing Company™, announces the granting of 44,893 restricted stock units (RSUs) to new employees as part of its 2023 Inducement Equity Incentive Plan. This initiative aligns with Nasdaq Listing Rule 5635(c)(4) and is specifically tailored for individuals who are new to the company, allowing Quantum-Si to attract top talent in the highly competitive field of proteomics. The vesting schedule for these RSUs is strategically designed, with 25% of the units vesting on March 20, 2026, followed by the remaining units vesting in 12 equal quarterly installments, contingent upon ongoing employment with the firm.

The decision to implement this equity incentive reinforces Quantum-Si's commitment to fostering innovation within the proteomics sector, particularly through its advanced Platinum® instruments. These instruments are at the forefront of Next-Gen Protein Sequencing™, which aims to revolutionize research in drug discovery and diagnostics. By incentivizing new hires with RSUs, Quantum-Si is not only enhancing its workforce but also promoting a culture of ownership among its employees, which is essential for driving the company's ambitious goals in protein sequencing.

Quantum-Si underscores the significance of this plan in the context of its growth strategy within the rapidly evolving proteomics landscape. As the company expands its capabilities and seeks to push the boundaries of current research methodologies, the ability to attract and retain skilled professionals is crucial. The press release accompanying the announcement also includes forward-looking statements regarding the company’s performance expectations, while cautioning stakeholders about various risks that could impact actual outcomes. These risks, which often lie beyond the company’s control, could affect the realization of Quantum-Si’s ambitious objectives and its product commercialization efforts.

In addition to the RSU plan, Quantum-Si continues to emphasize its focus on advancing proteomics, aiming to enhance the understanding of protein functions and interactions. The company invites interested parties to learn more about its initiatives and developments by visiting its website or following its social media channels. As Quantum-Si progresses in its mission, the new equity incentive serves as a critical tool for building a robust team capable of driving innovation within this vital scientific field.